Position in VNDA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$21,520,398
+$682,865 QoQ
Shares Held
3,516,405
+16.6% QoQ
Ownership
5.82%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. VNDA ranks #158 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in VNDA
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,520,398 | 3,516,405 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $20,837,533 | 3,015,562 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $20,837,533 | 3,015,562 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,144,413 | 1,263,539 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,342,684 | 1,271,079 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,974,797 | 1,265,847 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,749,245 | 1,252,559 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,670,703 | 1,183,863 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,464,703 | 1,165,182 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,843,895 | 1,211,309 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,945,542 | 1,203,295 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,182,565 | 1,228,096 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,632,333 | 1,303,781 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $26,891,391 | 4,080,636 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $30,907,482 | 4,551,912 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,548,427 | 3,727,798 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $36,411,267 | 3,685,351 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $40,503,582 | 3,715,925 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $45,955,900 | 4,063,298 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $52,207,423 | 3,327,433 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $58,242,439 | 3,398,042 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 ALXN | — | 10,033,808 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $68,004,058 | 3,161,509 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ALXN | — | 9,877,534 | Shares | Defined | 2021-07-09 | |
| 2021-03-31 | $49,751,331 | 3,312,339 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 ALXN | — | 10,628,834 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $42,099,298 | 3,203,904 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 ALXN | — | 11,139,445 | Shares | Defined | 2020-11-10 | |
| 2020-09-30 | $32,702,326 | 3,385,334 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 ALXN | — | 11,072,591 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $42,083,321 | 3,678,612 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 ALXN | — | 11,082,433 | Shares | Defined | 2020-06-19 | |
| 2020-03-31 | $29,380,089 | 2,835,916 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||